Gestational age at diagnosis of early-onset fetal growth restriction and impact on management and survival: a population-based cohort study
- PMID: 28266776
- DOI: 10.1111/1471-0528.14555
Gestational age at diagnosis of early-onset fetal growth restriction and impact on management and survival: a population-based cohort study
Abstract
Objective: To investigate the impact of gestational age (GA) at diagnosis of fetal growth restriction (FGR) on obstetric management and rates of live birth and survival for very preterm infants with early-onset FGR.
Design: Population-based cohort study.
Setting: All maternity units in 25 French regions in 2011.
Population: Fetuses diagnosed with FGR before 28 weeks of gestation among singleton births between 22 and 31 weeks of gestation without severe congenital anomalies.
Methods: We studied the effects of GA at diagnosis on perinatal management and outcomes. We used multivariable regression to identify antenatal factors (maternal characteristics, ultrasound measurements and sex) associated with the probability of live birth.
Main outcomes measures: Live birth and survival to discharge from neonatal care.
Results: A total of 436 of 3698 fetuses were diagnosed with FGR before 28 weeks (11.8%); 66.9% were live born and 54.4% survived to discharge. 50% were live born when diagnosis occurred before 25 weeks, 66% at 25 weeks and >90% at 26 and 27 weeks of gestation. In all, 94.1% of live births were by prelabour caesarean, principally for maternal indications before 26 weeks. Low GA at diagnosis, an estimated fetal weight or abdominal circumference below the third centile and male sex were adversely associated with live birth in adjusted models.
Conclusion: Gestational age at FGR diagnosis had an impact on the probability of live birth and survival, after consideration of other perinatal characteristics. Investigations of the outcomes of births with early-onset FGR need to include stillbirths and information on the GA at which FGR is diagnosed.
Tweetable abstract: Evaluations of active management of pregnancies with early onset growth restriction should include stillbirths.
Keywords: Diagnosis; fetal growth restriction; perinatal outcomes; very preterm birth.
© 2017 Royal College of Obstetricians and Gynaecologists.
Similar articles
-
Perinatal survival among very preterm singletons born after detection of early-onset fetal growth restriction with or without maternal hypertensive disorders: A population-based study in France.Eur J Obstet Gynecol Reprod Biol. 2023 Mar;282:43-49. doi: 10.1016/j.ejogrb.2023.01.004. Epub 2023 Jan 4. Eur J Obstet Gynecol Reprod Biol. 2023. PMID: 36634405
-
Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.Eur J Obstet Gynecol Reprod Biol. 2015 Oct;193:10-8. doi: 10.1016/j.ejogrb.2015.06.021. Epub 2015 Jul 2. Eur J Obstet Gynecol Reprod Biol. 2015. PMID: 26207980
-
Ten-year experience of protocol-based management of small-for-gestational-age fetuses: perinatal outcome in late-pregnancy cases diagnosed after 32 weeks.Ultrasound Obstet Gynecol. 2021 Jan;57(1):62-69. doi: 10.1002/uog.23537. Ultrasound Obstet Gynecol. 2021. PMID: 33159370
-
Isolated fetal umbilical vein varix and the association with intrauterine fetal death and fetal growth restriction: A systematic review, meta-analysis, and nested retrospective cohort study.Prenat Diagn. 2024 May;44(5):595-613. doi: 10.1002/pd.6538. Epub 2024 Mar 19. Prenat Diagn. 2024. PMID: 38502055
-
Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy.Am J Obstet Gynecol. 2018 Feb;218(2S):S855-S868. doi: 10.1016/j.ajog.2017.12.004. Am J Obstet Gynecol. 2018. PMID: 29422214 Review.
Cited by
-
Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis.Syst Rev. 2021 Dec 3;10(1):305. doi: 10.1186/s13643-021-01849-5. Syst Rev. 2021. PMID: 34861900 Free PMC article.
-
Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction.BMJ Open. 2019 Jun 22;9(6):e028243. doi: 10.1136/bmjopen-2018-028243. BMJ Open. 2019. PMID: 31230020 Free PMC article.
-
Cohort Profile: the Etude Epidémiologique sur les Petits Ages Gestationnels-2 (EPIPAGE-2) preterm birth cohort.Int J Epidemiol. 2021 Nov 10;50(5):1428-1429m. doi: 10.1093/ije/dyaa282. Int J Epidemiol. 2021. PMID: 34165536 Free PMC article. No abstract available.
-
Non-invasive prediction of fetal growth restriction by whole-genome promoter profiling of maternal plasma DNA: a nested case-control study.BJOG. 2021 Jan;128(2):458-466. doi: 10.1111/1471-0528.16292. Epub 2020 Jun 2. BJOG. 2021. PMID: 32364311 Free PMC article.
-
Detection of small for gestational age in preterm prelabor rupture of membranes by Hadlock versus the Fetal Medicine Foundation growth charts.Obstet Gynecol Sci. 2021 May;64(3):248-256. doi: 10.5468/ogs.20267. Epub 2021 Feb 9. Obstet Gynecol Sci. 2021. PMID: 33486918 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous